<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Global Life Sciences</title><link>https://www.sidley.com/zh-hans/rss/global-life-sciences</link><description /><language>zh-Hans</language><ttl>60</ttl><item><guid isPermaLink="false">{AA1A85DF-D46D-4AA2-86E5-3A6B34E51B78}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/04/most-favored-nation-drug-pricing-policy-executive-actions-manufacturer-agreements</link><category>盛德动态</category><title>Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional Scrutiny</title><description /><pubDate>Wed, 22 Apr 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{BB6EFD8B-217C-4D35-BC47-69283CB855BB}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/04/us-fda-issues-first-drug-supply-chain-security-act-warning-letter-targeting-a-dispenser</link><category>盛德动态</category><title>U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement Focus</title><description /><pubDate>Wed, 15 Apr 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{012B7DD6-9CE4-4C25-9BF7-C5C156F32FA4}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/04/white-house-and-doj-announce-sweeping-new-anti-fraud-initiatives</link><category>盛德动态</category><title>White House and DOJ Announce Sweeping New Anti-Fraud Initiatives</title><description /><pubDate>Fri, 10 Apr 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{DA5468F3-BA87-44F6-BB29-6C79D1EFBECB}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/03/market-access-another-favorable-medical-products-advisory-opinion-from-hhs</link><category>盛德动态</category><title>#Market Access: Another Favorable Medical Products Advisory Opinion from HHS-OIG Signals New Flexibilities</title><description /><pubDate>Thu, 19 Mar 2026 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{F0C3CAF2-12DD-4867-AAFE-0690BBE93F28}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/02/direct-to-consumer-prescription-drug-platforms-new-government-guidance-and-comment-opportunity</link><category>盛德动态</category><title>Direct-to-Consumer Prescription Drug Platforms: New Government Guidance and Comment Opportunity</title><description /><pubDate>Tue, 24 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{41D430B5-2A58-4250-B4B1-E7D35D2F624A}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/02/veterinary-biologics-and-biosimilars-routes-to-approval-and-commercialization-in-the-us-eu-and-uk</link><category>盛德动态</category><title>Veterinary Biologics and Biosimilars: Routes to Approval and Commercialization in the U.S., EU, and UK</title><description /><pubDate>Fri, 20 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{921CA9D9-9ABB-490B-8F6B-5264836A66D2}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/02/congress-passes-significant-federal-pharmacy-benefit-manager-reform-impacting-pharmaceutical-market</link><category>盛德动态</category><title>Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market Access</title><description /><pubDate>Wed, 18 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{41E7055D-B7A1-4411-856C-CCB7D4ED4406}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/02/oig-releases-long-awaited-medicare-advantage-compliance-program-guidance</link><category>盛德动态</category><title>OIG Releases Long-Awaited Medicare Advantage Compliance Program Guidance</title><description /><pubDate>Tue, 10 Feb 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{4FD37680-D6A6-4C4E-87FB-0EB723B27090}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/01/medical-products-market-access-favorable-advisory-opinion-reaffirms-discounting-flexibilities</link><category>盛德动态</category><title>Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting Flexibilities</title><description /><pubDate>Wed, 21 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{93EB3131-3AC6-4649-925E-BCD084C1C126}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/01/impact-of-fda-warning-letters-in-europe-practical-considerations-for-industry</link><category>盛德动态</category><title>Impact of U.S. FDA Warning Letters in Europe: Practical Considerations for Industry</title><description /><pubDate>Mon, 12 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{98235C28-1F65-4421-A2DB-3CB95D7832A0}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/01/top-10-areas-we-watching-for-2026</link><category>盛德动态</category><title>Top 10 FDA Areas We Are Watching For 2026</title><description>As 2026 begins, there is much to look forward to as companies and investors in the life sciences and medtech industries navigate a profoundly changing regulatory environment at FDA. With 2025 witnessing generational changes at FDA, we’re keeping an eye on opportunities and challenges for the year to come.</description><pubDate>Mon, 12 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{490F99D9-E289-43C4-A7D5-4630D04D2251}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2026/01/drugpricing-more-average-sales-price-proposals-and-new-comment-period</link><category>盛德动态</category><title>#DrugPricing: More Average Sales Price Proposals and New Comment Period</title><description /><pubDate>Tue, 06 Jan 2026 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{F92E55B6-B943-42C1-A6F7-51F6FD93208D}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/eu-biotech-act-eu-proposes-first-set-of-rules-to-facilitate-biopharmaceutical-competitiveness</link><category>盛德动态</category><title>EU Biotech Act: EU Proposes First Set of Rules to Facilitate Biopharmaceutical Competitiveness</title><description /><pubDate>Thu, 18 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{342BEDB1-41BF-4BFC-B5F7-720BB6C3BAA3}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/eu-pharma-package---sharp-new-tools-with-limited-protections</link><category>盛德动态</category><title>EU Pharma Package: Sharp New Tools With Limited Protections</title><description>Last week, concluding a seven-year process, the Council of the European Union and the European Parliament agreed on the EU Pharma Package consisting of a new Pharmaceutical Directive and Pharmaceutical Regulation. The Package introduces pivotal changes to the EU pharmaceutical legislation, most significantly the introduction of new launch and supply obligations with only limited safeguards and a reduction and modulation of regulatory data protection and market protection, requiring companies to re-think their pipeline strategies. The provisional agreement now needs to be endorsed by both the Council and the Parliament before being formally adopted and entering into force upon publication in the Official Journal of the European Union. The final text is expected to become available in the coming weeks.</description><pubDate>Thu, 18 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D92DA836-023B-4C42-B155-43A76622D984}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/us-drug-pricing-year-in-review-reflections-on-2025-and-getting-ready-for-2026</link><category>盛德动态</category><title>U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026</title><description /><pubDate>Thu, 11 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{80BB087E-FE40-4CAB-969D-7F1F33BA4490}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/what-the-us-uk-drug-pricing-agreement-reveals-about-how-mfn-drug-policy-could-impact-the-uk-and-eu</link><category>盛德动态</category><title>What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EU</title><description /><pubDate>Wed, 10 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{DB86E304-03FB-4EEB-BD07-617BE54EFB62}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/eu-digital-omnibus-implications-for-medtech-companies</link><category>盛德动态</category><title>EU Digital Omnibus Implications for MedTech Companies</title><description /><pubDate>Tue, 09 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{95E5F542-933E-4EC4-BFF5-0B1DDD6B50C5}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/us-fdas-adoption-of-ich-e6r3-good-clinical-practice-key-takeaways-for-sponsors-and-investigators</link><category>盛德动态</category><title>U.S. FDA's Adoption of ICH E6(R3) Good Clinical Practice: Key Takeaways for Sponsors and Investigators</title><description /><pubDate>Thu, 04 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{1FDB0166-E339-4D75-8C0B-6785F877CC64}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/12/medicare-payment-policy-final-rule-for-outpatient-setting-addresses-radiopharmaceuticals</link><category>盛德动态</category><title>Medicare Payment Policy Final Rule for Outpatient Setting Addresses Radiopharmaceuticals, Skin Substitutes, and 340B Program Key Topics</title><description /><pubDate>Tue, 02 Dec 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{475B293B-BC7A-4153-B69C-75EB1917ABED}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/11/us-fda-and-cms-actions-on-generative-ai-enabled-mental-health-devices-yield-insights-across-ai</link><category>盛德动态</category><title>U.S. FDA and CMS Actions on Generative AI-Enabled Mental Health Devices Yield Insights Across AI Product Development</title><description /><pubDate>Wed, 12 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{8A344660-AAA7-495D-9E49-06F7060CE33D}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/11/cms-announces-voluntary-most-favored-nation-pricing-in-medicaid-through-the-generous-model</link><category>盛德动态</category><title>CMS Announces Voluntary Most-Favored-Nation Pricing in Medicaid Through the GENEROUS Model</title><description /><pubDate>Tue, 11 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{44C55643-195A-43D1-BB34-E39A63E31A15}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/11/cms-finalizes-key-medicare-reimbursement-policies-for-telehealth-chronic-disease-and-digital-health</link><category>盛德动态</category><title>CMS Finalizes Key Medicare Reimbursement Policies for Telehealth, Chronic Disease, and Digital Health</title><description /><pubDate>Tue, 04 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{00A929E4-7CF6-4098-9C1B-9EF1F16E4FC7}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/10/major-changes-to-us-government-pricing-requirements-finalized-with-some-wins-for-pharma-and-biotech</link><category>盛德动态</category><title>Major Changes to U.S. Government Pricing Requirements Finalized, With Some Wins for Pharma and Biotech</title><description /><pubDate>Mon, 03 Nov 2025 06:00:00 Z</pubDate></item><item><guid isPermaLink="false">{19637343-5B32-4BB5-B697-0CE992600807}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/10/california-adds-second-law-in-one-week-targeting-healthcare-investments</link><category>盛德动态</category><title>California Adds Second Law in One Week Targeting Healthcare Investments</title><description /><pubDate>Tue, 14 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{B388160D-BB8A-4DE5-8EC9-D5A749A68BBC}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/10/inflation-reduction-act-cms-publishes-final-guidance-for-initial-price-applicability-year-2028</link><category>盛德动态</category><title>Inflation Reduction Act: CMS Publishes Final Guidance for Initial Price Applicability Year 2028</title><description /><pubDate>Thu, 09 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{88576A72-1092-4C80-A0CC-37B58E53CBF6}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/10/newly-enacted-california-law-formalizes-corporate-practice-restrictions</link><category>盛德动态</category><title>Newly Enacted California Law Formalizes Corporate Practice Restrictions</title><description /><pubDate>Wed, 08 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{1964174B-39C5-4B1A-93CC-7012B1EAAEF1}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/10/adapting-to-change-key-compliance-risks-under-the-revised-eu-pharmacovigilance-rules</link><category>盛德动态</category><title>Adapting to Change Key Compliance Risks Under the Revised EU Pharmacovigilance Rules</title><description /><pubDate>Wed, 08 Oct 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{AF380A21-D395-4F81-BEAE-911D8DB3FC91}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/09/paths-forward-in-the-wake-of-fdas-crackdown-on-prescription-drug-ads</link><category>盛德动态</category><title>Paths Forward in the Wake of FDA’s “Crackdown” on Prescription Drug Ads</title><description /><pubDate>Fri, 26 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{6A6D70B5-5491-48D8-B056-C8BF0A3E3771}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/09/fdas-alternative-tools-guidance-promises-a-flexible-approach-for-manufacturing-facility-assessments</link><category>盛德动态</category><title>FDA’s Alternative Tools Guidance Promises a Flexible Approach for Manufacturing Facility Assessments</title><description /><pubDate>Thu, 18 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{BF0282C1-A3F0-44DF-8C88-39CF1DD3B08C}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/09/rare-disease-and-specialty-product-manufacturers-distribution-model-considerations</link><category>盛德动态</category><title>Rare Disease and Specialty Product Manufacturers: Distribution Model Considerations</title><description /><pubDate>Tue, 16 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{49A07424-2E82-4BAD-83A4-460050DA52A8}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/09/evolving-veterinary-pharmacovigilance-frameworks-in-europe</link><category>盛德动态</category><title>Evolving Veterinary Pharmacovigilance Frameworks in Europe: What Manufacturers Need to Know</title><description /><pubDate>Mon, 15 Sep 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{DF68F06A-2D8F-4A9C-B350-D14FCF017593}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/08/new-digital-health-ecosystem-and-hipaa-flexibilities-facilitate-sharing-of-patient</link><category>盛德动态</category><title>New Digital Health Ecosystem and HIPAA Flexibilities Facilitate Sharing of Patient Health Information</title><description /><pubDate>Fri, 29 Aug 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D38838EF-BA7C-4331-860B-F3BE13CEC17A}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/lab-compliance-companion-diagnostic-testing-arrangement-approved-by-hhs</link><category>盛德动态</category><title>Lab Compliance: Companion Diagnostic Testing Arrangement Approved by HHS Office of Inspector General</title><description /><pubDate>Thu, 24 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{6D41037F-641F-4DC2-A995-0E34D1E7180D}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/key-medicare-reimbursement-policies-under-the-microscope-in-proposed-rule</link><category>盛德动态</category><title>Key Medicare Reimbursement Policies Under the Microscope in Proposed Rule</title><description /><pubDate>Thu, 24 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{D691DE81-A1E2-4913-ABD3-2AE86BBD9BF3}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/early-stage-life-sciences-partnerships-raise-later-stage-considerations</link><category>盛德动态</category><title>Early-Stage Life Sciences Partnerships Raise Later-Stage Considerations</title><description /><pubDate>Mon, 21 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{47167045-1268-4DB1-8F1E-A944DE3A6FCE}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/major-us-government-price-reporting-proposals-warrant-industry-comment</link><category>盛德动态</category><title>Major U.S. Government Price Reporting Proposals Warrant Industry Comment</title><description /><pubDate>Fri, 18 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{3A941B0D-581A-443F-9F7A-255DD9C318C6}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/key-inflation-reduction-act-amendment-broadens-us-protection-for-orphan-drugs</link><category>盛德动态</category><title>Key Inflation Reduction Act Amendment Broadens U.S. Protection for Orphan Drugs</title><description /><pubDate>Tue, 15 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{2698812C-71F6-4D9A-90B5-A27A7426A3F7}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/fda-release-of-complete-response-letters-raises-confidentiality-and-disclosure-questions</link><category>盛德动态</category><title>FDA Release of Complete Response Letters Raises Confidentiality, Disclosure Questions But Offers Insights for Development</title><description /><pubDate>Fri, 11 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{28FABD1C-59B8-4743-8000-AF407F07050F}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/07/us-fda-publishes-final-guidance-for-remote-regulatory-assessments</link><category>盛德动态</category><title>U.S. FDA Publishes Final Guidance for Remote Regulatory Assessments</title><description /><pubDate>Mon, 07 Jul 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{B74B9AC0-0EE8-4535-BA68-D56B80F05B2B}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/06/eu-limits-chinese-participation-in-medical-devices-procurement</link><category>盛德动态</category><title>EU Limits Chinese Participation in Medical Devices Procurement</title><description /><pubDate>Mon, 30 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{E828ED31-5CEF-43A4-9D38-AD21FBB33AC0}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/06/us-fda-revises-deadline-for-submitting-changes-to-mitigate-nitrosamine-impurities-in-drugs</link><category>盛德动态</category><title>U.S. FDA Revises Deadline for Submitting Changes to Mitigate Nitrosamine Impurities in Drugs (June 2025)</title><description /><pubDate>Wed, 25 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{1AA46C29-13F0-4C2D-B2EC-BB6EABFE0D91}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/06/fda-finalizes-guidance-for-generic-drug-manufacturers-seeking-post-warning-letter-meetings</link><category>盛德动态</category><title>FDA Finalizes Guidance for Generic Drug Manufacturers Seeking Post-Warning Letter Meetings</title><description /><pubDate>Tue, 24 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{63F34AF7-75A9-47CA-A65A-0E60CDF2179C}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/06/us-doj-civil-division-to-investigate-possible-violations-of-the-fdca-by-pharmaceutical-companies</link><category>盛德动态</category><title>U.S. DOJ Civil Division to Investigate Possible Violations of the Food, Drug, and Cosmetic Act by Pharmaceutical Firms Manufacturing Drugs Used in Gender Transition Care</title><description /><pubDate>Mon, 23 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{C9D19280-CAFF-4912-A6C8-38ADE25CAE62}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/06/oregon-revises-corporate-practice-of-medicine-law</link><category>盛德动态</category><title>Oregon Revises Corporate Practice of Medicine Law: Implementing More Restrictions on Corporate Involvement in Medical Practices</title><description /><pubDate>Thu, 12 Jun 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{967F4A66-66EB-4B97-B7FF-18BA6D3CDAA5}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/us-cms-sets-stage-for-2028-medicare-drug-price-negotiations</link><category>盛德动态</category><title>CMS Sets Stage for 2028 Medicare Drug Price Negotiations — First Look at Negotiations for Part B</title><description /><pubDate>Wed, 21 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{9156F783-236E-4EE7-A4DB-AC1D3DCA0390}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/most-favored-nation-drug-pricing-executive-order-signals-potential-us-major-policy-shift</link><category>盛德动态</category><title>Most-Favored-Nation Drug Pricing: Executive Order Sets Forth Potential U.S. Major Policy Shift</title><description /><pubDate>Thu, 15 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{074DB137-0752-4964-B534-3CD8ACD17443}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/strict-liability-in-the-crosshairs-executive-order-reshapes-criminal-enforcement-of-the-fdca</link><category>盛德动态</category><title>Strict Liability in the Crosshairs: Executive Order Reshapes Criminal Enforcement of the U.S. Federal Food, Drug, and Cosmetic Act</title><description /><pubDate>Wed, 14 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{E15D1216-BEB2-4DCD-ABDE-C6D92A5573BB}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/medicare-reimbursement-pathway-for-ai-enabled-medical-devices-considered</link><category>盛德动态</category><title>Medicare Reimbursement Pathway for AI-Enabled Medical Devices Considered in Senate’s Health Tech Investment Act</title><description /><pubDate>Tue, 13 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{04C0D967-F7F5-4948-8937-4B1F9554D00F}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/us-fda-plans-to-increase-the-number-of-surprise-foreign-inspections</link><category>盛德动态</category><title>U.S. FDA Plans to Increase the Number of Surprise Foreign Inspections</title><description /><pubDate>Wed, 07 May 2025 05:00:00 Z</pubDate></item><item><guid isPermaLink="false">{2AE68683-F756-4F18-BF85-C38B7724D7C7}</guid><link>https://www.sidley.com/zh-hans/insights/newsupdates/2025/05/federal-court-clarifies-medicaid-rebate-reporting-requirements-for-new-strengths</link><category>盛德动态</category><title>Federal Court Clarifies Medicaid Rebate Reporting Requirements for New Strengths</title><description /><pubDate>Wed, 07 May 2025 05:00:00 Z</pubDate></item></channel></rss>